Tal Buntinx, MD
Dermatology · Middletown, RINPI 1013446590
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,896 of the $3,266 with a category attached, or 88.7%. It is spread thinly across 14 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $830, 2.3 times the $367 reported in 2019.
Across 107 payments — averaging $30.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$635
- Pfizer$519
- Johnson & Johnson$442
- Novartis$311
- AbbVie$309
- Sanofi$243
- plus $807 from 8 others
What the payments were for
- Food & beverage$2,89689%
- Education$37011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 15 | $635 |
| Pfizer | 26 | $519 |
| Johnson & Johnson | 15 | $442 |
| Novartis | 14 | $311 |
| AbbVie(2 entities) | 4 | $309 |
| Sanofi | 6 | $243 |
| LEO Pharma Inc. | 9 | $221 |
| Regeneron Healthcare Solutions, Inc. | 2 | $213 |
| VYNE Pharmaceuticals Inc. | 1 | $120 |
| Organon | 5 | $75 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $73 |
| Lilly USA, LLC | 3 | $54 |
| Galderma Laboratories, L.p. | 2 | $34 |
| Dermavant Sciences, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,266 in reported general payments places this provider in the 65th percentile of 61 dermatology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 12 | $273,749 |
| Fluocinonide | 147 | $7,825 |
| Ketoconazole | 256 | $4,313 |
| Tacrolimus | 30 | $4,048 |
| Metronidazole | 40 | $2,666 |
| Triamcinolone Acetonide | 124 | $1,704 |
| Clobetasol Propionate | 42 | $1,675 |
| Doxycycline Hyclate | 48 | $1,374 |
| Clindamycin Phosphate | 34 | $1,233 |
| Mupirocin | 47 | $398 |
| Hydrocortisone | 47 | $378 |
| ValacyclovirValacyclovir Hcl | 18 | $358 |
| MethotrexateMethotrexate Sodium | 13 | $256 |
| Ciclopirox | 18 | $234 |
| Minoxidil | 24 | $160 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Middletown
- Gary WatermanMiddletown$16K
- Victoria ComeauMiddletown$7K
- Antoine SalloumMiddletown$4K
- Sarah BeldenMiddletown$3K
- John KellyEast Greenwich$97K
- Helena KuhnProvidence$63K
- Martin WeinstockProvidence$62K
- Farah MoustafaProvidence$51K
- Carlos WambierSouth Kingstown$41K
- Abrar QureshiProvidence$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.